OUTCOME OF CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA (APML) TREATED WITH SEQUENTIAL ARSENIC TRIOXIDE (ATO) AND ALL TRANS RETINOIC ACID (ATRA) BASED THERAPY: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTRE

被引：0
|
作者：
Panda, S. P. [1 ]
Pradhan, N. D. [1 ]
Shah, N. [1 ]
Prasad, M. [1 ]
Vora, T. [1 ]
Narula, G. [1 ]
Chinnaswamy, G. [1 ]
Subramanyam, P. G. [1 ]
Chougule, A. [1 ]
Amre, P. [2 ]
Arora, B. [1 ]
Kurkure, P. [1 ]
Banavali, S. D. [1 ]
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
[2] Tata Mem Hosp, Canc Cytogenet Lab, Bombay 400012, Maharashtra, India
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-129
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [1] Prolonged Arsenic Trioxide (ATO) and All- Trans Retinoic Acid (ATRA) Therapy for Relapsed Acute Promyelocytic Leukemia
    Cicconi, Laura
    Breccia, Massimo
    Franceschini, Luca
    Latagliata, Roberto
    Molica, Matteo
    Rizzo, Manuela
    Divona, Mariadomenica
    Iaccarino, Licia
    Ottone, Tiziana
    Alfonso, Valentina
    Foa, Robin
    Voso, Maria Teresa
    Lo Coco, Francesco
    BLOOD, 2017, 130
  • [2] SAFETY AND EFFICACY OF ALL-TRANS RETINOIC ACID (ATRA) AND ARSENIC TRIOXIDE (ATO) COMBINATION THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA
    Arora, A.
    Malhotra, P.
    Das, R.
    Varma, S.
    Suri, V.
    Varma, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 272 - 272
  • [3] Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy
    Laura Cicconi
    Massimo Breccia
    Luca Franceschini
    Roberto Latagliata
    Matteo Molica
    Mariadomenica Divona
    Daniela Diverio
    Manuela Rizzo
    Tiziana Ottone
    Licia Iaccarino
    Valentina Alfonso
    Robin Foa
    Maria Teresa Voso
    Francesco Lo-Coco
    Annals of Hematology, 2018, 97 : 1797 - 1802
  • [4] Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy
    Cicconi, Laura
    Breccia, Massimo
    Franceschini, Luca
    Latagliata, Roberto
    Molica, Matteo
    Divona, Mariadomenica
    Diverio, Daniela
    Rizzo, Manuela
    Ottone, Tiziana
    Iaccarino, Licia
    Alfonso, Valentina
    Foa, Robin
    Voso, Maria Teresa
    Lo-Coco, Francesco
    ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1797 - 1802
  • [5] Incidence of Secondary Neoplasms In Patients with Acute Promyelocytic Leukemia Treated with All-Trans-Retinoic Acid (ATRA) with Chemotherapy or with Arsenic Trioxide (ATO)
    Eghtedar, Alireza
    Faderl, Stefan
    Kantarjian, Hagop
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Ferrajoli, Alessandra
    Kadia, Tapan
    Pierce, Sherry A.
    Shan, Jenny
    Cortes, Jorge E.
    Ravandi, Farhad
    BLOOD, 2010, 116 (21) : 474 - 474
  • [6] THROMBIN GENERATION POTENTIAL OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) CELLS TREATED WITH ARSENIC TRIOXIDE (ATO) AND ALL-TRANS RETINOIC ACID (ATRA)
    Marchetti, M.
    Diani, E.
    Russo, L.
    Balducci, D.
    Falanga, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 293 - 293
  • [7] Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
    Colita, Andrei
    Tanase, Alina Daniela
    Tomuleasa, Ciprian
    Colita, Anca
    CANCERS, 2023, 15 (16)
  • [8] Combination therapy with arsenic trioxide (ATO), all-trans retinoic acid (ATRA), and gemtuzumab ozogamycin (GO) in relapsed acute promyelocytic leukemia (APL).
    Aribi, A. M.
    Kantarjian, H.
    Estey, E.
    Freireich, E.
    Koller, C.
    Thomas, D.
    Kornblau, S.
    Faderl, S.
    Laddie, N.
    Garcia-Manero, G.
    Cortes, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 351S - 351S
  • [9] All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
    Iland, Harry J.
    Bradstock, Ken
    Supple, Shane G.
    Catalano, Alberto
    Collins, Marnie
    Hertzberg, Mark
    Browett, Peter
    Grigg, Andrew
    Firkin, Frank
    Hugman, Amanda
    Reynolds, John
    Di Iulio, Juliana
    Tiley, Campbell
    Taylor, Kerry
    Filshie, Robin
    Seldon, Michael
    Taper, John
    Szer, Jeff
    Moore, John
    Bashford, John
    Seymour, John F.
    BLOOD, 2012, 120 (08) : 1570 - 1580
  • [10] OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH THE COMBINATION OF ALL-TRANS RETINOIC ACID (ATRA), ARSENIC TRIOXIDE (ATO), WITH OR WITHOUT GEMTUZUMAB OZOGAMICIN (GO)
    Ravandi, F.
    Cortes, J.
    Fader, S.
    O'Brien, S.
    Pierce, S.
    Brandt, M.
    Garcia-Manero, G.
    Kantarjian, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 224 - 224
12345